Condition: Ovarian Cancer · Sponsor: Chang Gung Memorial Hospital
A prospective cohort imaging study in a single institution to evaluate 68Ga- FAPI-46 and 18F-FDG PET/CT imaging for detecting recurrent tumor lesions in patients of ovarian cancer with CA125 elevation from complete response after therapy
This description comes directly from the study's public registry record.
Feng-Yuan Liu · 0975365782 · billliu@cgmh.org.tw
Always discuss trial participation with your own doctor first.
| Chang-Gung Memorial Hospital, Linkou Branch | Taoyuan City, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06232122